Stock·NYSE·Real Estate
Vivmark Residential (VMRK)
- Market cap
- $48.40B
- Dividend yield
- 4.48%
- Street target
- $71.50median of 22 analysts
- 52-week range
- $57.57 $71.50
VMRK stock forecast today
Where VMRK stands today, and what CleaRank Financial AI makes of it.
VMRK at a glance
Vivmark Residential (VMRK): Hold, 49/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($63.09 and $63.99).
- Insiders Insiders sold $4.7M and made no open-market purchases over the last 18 months.
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Vivmark Residential (VMRK) Hold with a model score of 49/100.
The biggest lift comes from the analysts' outlook, where the median target is 14.3% above the price. The biggest drag comes from the trend: the price is 2.25% below its 200-day average and 0.86% below its 50-day average, and the 50-day average is 1.40% below the 200-day. The two averages stand at $63.09 for the 50-day and $63.99 for the 200-day. Across the past year the price dropped 1.20%.
Only on CleaRank
Figures we compute ourselves from VMRK's own price, earnings and insider-filing history. Tap one to see it in context.
VMRK stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $62.55 is 0.9% below the 50-day simple moving average of $63.09.Price above its 200-day average ›
The price is 2.3% below the 200-day simple moving average of $63.99.50-day average above the 200-day ›
The 50-day average ($63.09) is 1.4% below the 200-day average ($63.99), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 36% of its 52-week range, between $57.57 and $71.50.
VMRK share price
Pick a period: each tab shows how far VMRK has moved over it, to the last close.
Today's trading
Where VMRK sits inside today's range and its 52-week range.
VMRK fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/S below the sector median ›
The price-to-sales ratio of 15.78 is 51.8% above the sector median of 10.4.Profitable over the last 12 months ›
Net income over the last 12 months was $1.0B on revenue of $3.1B, a net margin of 33.3%.Pays a dividend ›
The trailing dividend yield is 4.48%, or $2.80 a share a year.
Key statistics
The headline figures for VMRK.
As of October 27, 2026, VMRK trades at $62.55, with a market value of $48.40B and a dividend yield of 4.48%.
What the numbers say
CleaRank Financial AI's reading of VMRK's valuation, growth and risks.
VMRK changes hands at 15.78 times sales, a multiple that is 51.7% above the sector median of 10.4. Its market capitalisation is $48.4B.
With revenue growth of 3.30%, VMRK is 7.7 percentage points slower than the sector median of 11.0%. Profitability shows a net margin of 33.25% and an operating margin of 29.50%, with a return on equity of 8.49%, above the sector median of 5.8%. The balance sheet and payout round out the picture, with debt-to-equity of 0.75 and a trailing dividend yield of 4.48% ($2.80 a share a year).
Analysts forecast EPS of $1.49 for this fiscal year and $1.47 for the year after, which would be a decline of 1.2%.
Expect day-to-day swings: VMRK has moved 1.13% in an average session, and its beta against the S&P 500 is 0.57. The trend is a headwind for holders until the price climbs back above its moving averages. Over the last 18 months insiders sold $4.7M of stock and bought none on the open market. Such sales are often scheduled ahead of time, so they tell less than purchases would.
VMRK against the Real Estate sector
How VMRK compares with the median Real Estate stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, VMRK trades at 15.78x, +52% versus the sector average of 10.40x.
Return vs XLRE: Since May 15, 2025, VMRK has lost 11.7% against a gain of 2.3% for XLRE.
Performance against XLRE
VMRK and the Real Estate sector fund over the same days.
Revenue and earnings
How much VMRK sells, and how much of it becomes profit.
Profitable: VMRK earned $1.1B in FY2025.
VMRK AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/2RSI not overbought or oversold ›
The 14-day RSI is 53.4, in neutral territory.RSI above 50 ›
An RSI of 53.4 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.
CleaRank Financial AI analysis of VMRK
The score, the reasoning behind it, and what could move the price next.
Vivmark Residential (VMRK) is in a downtrend. The price of $62.55 sits 2.25% below its 200-day average of $63.99 and 0.86% below its 50-day average of $63.09. The 50-day average is 1.40% below the 200-day, a gap that backs up the weak trend instead of cutting against it. Across its 52-week range, which runs from $57.57 to $71.50, the price stands at 36%, and it is 12.52% below the high.
The longer record is weaker than the recent bounce. The price is up 1.69% over the past month, yet it is down 8.14% over the past three months and down 1.20% over the past year. Last session volume was 30.1% below its average on a day when the price slipped 0.37%. At 53.4, the 14-day RSI sits in the neutral zone.
Rating reaffirmed ›
Wells Fargo kept its Overweight rating on October 19, 2026.
Source: Analyst action, Wells Fargo, October 19, 2026
- The two closest levels to track are the 50-day SMA at $63.09, just above the price, and the 20-day EMA at $61.93, just below it.
- The 14-day RSI is 53.4, which is neutral. Readings above 70 or below 30 would signal stretched momentum.
VMRK is priced under both its 50-day ($63.09) and 200-day ($63.99) averages, and that is why the trend reads down. A move back above the 50-day would be the first sign of repair. The nearest level above the price is the 50-day SMA at $63.09.
The next marker below the price is the 20-day EMA at $61.93. The 14-day RSI of 53.4 places momentum in the neutral band, between 40 and 60.
Technical indicators
Momentum and trend for VMRK, from its daily closes.
As of October 27, 2026, with VMRK at $62.55, its 14-day RSI is 53.4 (neutral territory), its 50-day simple moving average is $63.09 and its 200-day is $63.99.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What VMRK moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, VMRK's 1-year correlation of daily returns is +0.37 with S&P 500 (SPY), +0.20 with Nasdaq 100 (QQQ), +0.07 with Bitcoin (BTC) and +0.03 with gold (XAU).
VMRK price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
10 of 22 analysts rate it a buy or strong buy, 12 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $71.50 is 14.3% above the price.More buy ratings than three months ago ›
10 of 22 rate it a buy now, against 5 of 20 three months ago.
VMRK Wall Street View
12-month price targets
The price, $62.55, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 19, 2026 | Wells Fargo | Maintains | Overweight |
| Oct 14, 2026 | UBS | Maintains | Buy |
| Oct 14, 2026 | Barclays | Maintains | Equal-Weight |
| Oct 13, 2026 | RBC Capital | Maintains | Sector Perform |
| Oct 12, 2026 | Piper Sandler | Maintains | Neutral |
| Sep 21, 2026 | Evercore ISI Group | Maintains | In-Line |
As of October 27, 2026, 22 Wall Street analysts cover VMRK: 10 rate it a buy or strong buy, 12 a hold and 0 a sell or strong sell. Their 12-month price targets range from $63.00 to $80.00. The median VMRK price target is $71.50, 14.3% above the price of $62.55.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
VMRK trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
VMRK trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from VMRK's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much VMRK tends to move, against the market and on its own.
VMRK price history and drawdowns
VMRK's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.13% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 41.9%, from October 2019 to October 2020, regained by July 2021.Most 1-year holds ended higher ›
56% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $14,960, against $42,376 in the S&P 500 (SPY).
VMRK Drawdowns & Recovery
As of October 27, 2026, VMRK's worst peak-to-trough fall over the last 10 years with dividends reinvested was -41.9% (October 2019 to October 2020); it regained that peak by July 2021, 9 months after the low, and 56% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into VMRK in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: VMRK trailed the S&P 500 over this period: $14,960 against $42,376.
A $10,000 investment in VMRK in October 2016 would be worth about $14,960 today with dividends reinvested, compared with about $42,376 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to VMRK, and which have not.
Strongest month, April: an average of +4.16%, up in 9 of 10 years.
Weakest month, September: an average of -4.26%, up in 2 of 10 years.
This month, October: has averaged -0.50%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, VMRK's strongest calendar month has been April (average +4.16%, up in 9 of 10 years) and its weakest September (average -4.26%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
VMRK stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in VMRK, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in VMRK today could grow to about $11,405 by 2030 in the base case, with a 90th-percentile outcome near $21,740 and a 10th-percentile outcome around $5,984. The simulation models price only; at today's 4.48% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
VMRK Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $71.34 for VMRK by 2030 in the base case, from $62.55 today (1.1x over 4 years). The 10th-percentile path ends near $37.43. These are outcomes of a Monte Carlo simulation run on VMRK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $46.82 | $64.64 | $89.24 | |
| 2028 | $42.33 | $66.80 | $105 | |
| 2029 | $39.49 | $69.03 | $121 | |
| 2030 | $37.43 | $71.34 | $136 |
Method: a lognormal simulation of VMRK's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
VMRK insider trading
What the people running the company have bought and sold.
VMRK insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought VMRK shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 27, 2026, VMRK insiders reported 15 open-market sales worth $4.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Chris Carr
Director
|
Sell | 1.1K | $73.8K |
| Aug 31, 2026 | Scott J. Fenster
General Counsel
|
Grant | 4.6K | - |
| Aug 31, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 34.6K | - |
| Aug 21, 2026 | Sean Thomas Willson
Officer
|
Sell | 300 | $19.9K |
| Aug 20, 2026 | Matthew H Birenbaum
Officer
|
Grant | 1.4K | - |
| Aug 19, 2026 | Sean Thomas Willson
Officer
|
Sell | 250 | $16.1K |
| Aug 18, 2026 | Edward M Schulman
Officer
|
Sell | 16.6K | $1.1M |
| Aug 18, 2026 | Susan Swanezy
Director
|
Sell | 15.7K | $1.0M |
| Aug 18, 2026 | Christopher Howard
Director
|
Sell | 8.5K | $543.1K |
| Aug 18, 2026 | Charles E. Mueller Jr.
Director
|
Sell | 8.0K | $511.2K |
| Aug 17, 2026 | Michael L Manelis
Chief Operating Officer
|
Sell | 7.8K | $503.2K |
| Aug 17, 2026 | Matthew H Birenbaum
Officer
|
Grant | 35.9K | - |
| Aug 17, 2026 | Chris Carr
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Mary Kay Haben
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Ann C. Hoff
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Nina P. Jones
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 8.8K | - |
| Aug 17, 2026 | Timothy James Naughton
Director
|
Grant | 2.6K | - |
| Aug 17, 2026 | Stephen E Sterrett
Chairman of the Board
|
Grant | 2.6K | - |
| Aug 17, 2026 | Pamela Rogers Thomas
Officer
|
Grant | 56.7K | - |
| Aug 17, 2026 | Sean Thomas Willson
Officer
|
Grant | 6.0K | - |
| Aug 14, 2026 | Ian Kaufman
Officer
|
Grant | 30 | $1.7K |
| Jun 18, 2026 | Mary Kay Haben
Director
|
Grant | 3.3K | - |
| Jun 18, 2026 | Ann C. Hoff
Director
|
Grant | 3.3K | - |
| Jun 18, 2026 | Nina P. Jones
Director
|
Grant | 3.3K | - |
| Jun 18, 2026 | Stephen E Sterrett
Director
|
Grant | 3.3K | - |
| May 14, 2026 | Ian Kaufman
Officer
|
Grant | 32 | $1.7K |
| Mar 2, 2026 | Ian Kaufman
Officer
|
Grant | 150 | $7.9K |
| Feb 18, 2026 | Michael L Manelis
Chief Operating Officer
|
Sell | 2.4K | $154.4K |
| Feb 18, 2026 | Ian Kaufman
Officer
|
Sell | 909 | $57.8K |
| Feb 18, 2026 | Catherine Carraway
Officer
|
Sell | 749 | $47.6K |
| Feb 10, 2026 | Michael L Manelis
Chief Operating Officer
|
Sell | 5.8K | $375.5K |
| Feb 10, 2026 | Robert A Garechana
Chief Investment Officer
|
Sell | 3.6K | $236.9K |
| Feb 10, 2026 | Catherine Carraway
Officer
|
Sell | 656 | $42.7K |
| Feb 9, 2026 | Catherine Carraway
Officer
|
Grant | 4.8K | - |
| Feb 9, 2026 | Scott J. Fenster
General Counsel
|
Grant | 9.2K | - |
| Feb 9, 2026 | Ian Kaufman
Officer
|
Grant | 4.6K | - |
| Feb 9, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 12.0K | - |
| Feb 9, 2026 | Bret D. Mcleod
Chief Financial Officer
|
Grant | 6.8K | - |
| Feb 9, 2026 | Mark J Parrell
Chief Executive Officer
|
Grant | 19.9K | - |
| Jan 16, 2026 | Catherine Carraway
Officer
|
Grant | 3.0K | - |
| Jan 16, 2026 | Robert A Garechana
Chief Investment Officer
|
Grant | 11.0K | - |
| Jan 16, 2026 | Michael L Manelis
Chief Operating Officer
|
Grant | 13.1K | - |
| Dec 30, 2025 | David J Neithercut
Chairman of the Board
|
Grant | 42.5K | - |
| Nov 14, 2025 | Ian Kaufman
Officer
|
Grant | 39 | $2.0K |
| Aug 14, 2025 | Ian Kaufman
Officer
|
Grant | 37 | $2.0K |
| Aug 14, 2025 | Stephen E Sterrett
Director
|
Grant | 1.9K | $100.0K |
| Aug 7, 2025 | Chris Carr
Director
|
Grant | 3.0K | - |
| Aug 7, 2025 | Bret D. Mcleod
Chief Financial Officer
|
Grant | 19.6K | - |
| Jul 1, 2025 | Linda Walker Bynoe
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Mary Kay Haben
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Ann C. Hoff
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Nina P. Jones
Director
|
Grant | 3.1K | - |
| Jul 1, 2025 | Stephen E Sterrett
Director
|
Grant | 3.1K | - |
| May 14, 2025 | Ian Kaufman
Officer
|
Grant | 24 | $1.4K |
| May 1, 2025 | Catherine Carraway
Officer
|
Sell | 1.0K | $71.0K |
Source: TwelveData, from SEC Form 4 filings
VMRK stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.